Yes, certain populations are more susceptible to adverse effects. Pregnant women, children, and individuals with pre-existing liver or kidney conditions require careful consideration. Additionally, genetic factors can influence drug metabolism, making pharmacogenomics an essential aspect of personalized medicine.
